Press Releases April 24, 2026 09:06 AM

Sunlands Technology Group Files its Annual Report on Form 20-F

Sunlands Technology Group Files Annual 20-F Report for Fiscal Year 2025

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
STG

Sunlands Technology Group, a leading Chinese adult online education provider, has filed its annual report on Form 20-F with the U.S. SEC for the fiscal year ended December 31, 2025. The report includes audited financial statements and is accessible on both the SEC and company websites. The filing reaffirms Sunlands' commitment to transparency and regulatory compliance as a U.S.-listed company.

Sunlands Technology Group Files its Annual Report on Form 20-F
STG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Sunlands operates in China's adult online education and personal interest learning markets, with offerings spanning post-secondary degree courses and professional certifications.
  • The company uses a proprietary Learning Outcome Trees system to tailor educational content to student needs, enhancing personalized learning experiences.
  • Annual report filing provides detailed audited financials, supporting investor transparency and confidence.

BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the “SEC”) on April 24, 2026, U.S. Eastern Time.

The annual report can be accessed on the Company’s investor relations website at https://ir.sunlands.com and on the SEC’s website at www.sec.gov. The Company will provide a hard copy of the annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to sl-ir@sunlands.com.

About Sunlands

Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), formerly known as Sunlands Online Education Group, is a leader in China’s adult online education market and China’s adult personal interest learning market. With a one to many live streaming platform, Sunlands offers various degree- or diploma-oriented post-secondary courses as well as professional certification preparation, professional skills and interest courses. Students can access the Company’s services either through PC or mobile applications. The Company’s online platform cultivates a personalized, interactive learning environment by featuring a virtual learning community and a vast library of educational content offerings that adapt to the learning habits of its students. Sunlands offers a unique approach to education research and development that organizes subject content into Learning Outcome Trees, the Company’s proprietary knowledge management system. Sunlands has a deep understanding of the educational needs of its prospective students and offers solutions that help them achieve their goals.

For more information, please visit https://ir.sunlands.com.

For investor and media inquiries, please contact:

Sunlands Technology Group
Investor Relations
Email: sl-ir@sunlands.com

SOURCE: Sunlands Technology Group


Risks

  • Regulatory changes in either U.S. or China could impact operations or reporting requirements for Sunlands.
  • Market competition in the online education sector in China remains intense, potentially affecting growth and profitability.
  • Dependence on technology platforms (PC and mobile apps) may expose the company to technical disruptions or cybersecurity risks.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026